Estrogen/autophagy/ECSCR regulatory axis in vascular endothelial cells facilitates angiogenesis in endometriosis
Lab / animal
OA: closed
public-domain-us
Abstract
INTRODUCTION: Aberrant angiogenesis contributes greatly to endometriosis (EMs) progression, whereas the biological dysfunction of vascular endothelial cells (VECs) in EMs ectopic lesions and the underlying molecular regulatory mechanisms remain largely elusive.
METHODS: To uncover the characteristics of VECs and their microenvironment, as well as the key regulatory mechanisms underlying this dysfunctional state in EMs lesions, the proportions of VEC clusters in normal endometrium and EMs lesions were determined by analyzing single-cell RNA sequencing (scRNA-seq) data and verified by immunohistochemistry. The expression levels of VEC markers (such as vWF, CDH5, PECAM-1, and CD34) and genes enriched in angiogenesis-, autophagy-, and cytoskeleton formation-related pathways were analyzed in Gene Expression Omnibus (GEO) datasets. In addition, qRT-PCR, western blotting, autophagy detection, cytoskeleton formation, tube formation, and wound healing assays were performed in vitro. Furthermore, EMs mouse models were established in vivo to verify the pro-angiogenic state of ectopic lesions under high-estrogen and enhanced-autophagy conditions.
RESULTS: We found that EMs lesions displayed increased vascular density, aberrant angiogenesis, and a characteristic pro-angiogenic microenvironment. Autophagy levels and cytoskeleton formation in VECs were also significantly increased in EMs. In addition, upregulating autophagy in VECs greatly contributed to accelerated angiogenesis both in vitro and in vivo. Estrogen treatment promoted autophagy in VECs by upregulating estrogen receptor α (ERα) expression. Estrogen-mediated autophagy augmentation also promoted cytoskeleton formation, migration, and tube formation in VECs by downregulating endothelial cell-specific chemotaxis receptor (ECSCR) expression. Moreover, ECSCR expression showed a decreasing trend in EMs VECs compared to VECs in normal endometrium.
CONCLUSIONS: In conclusion, high estrogen levels in EMs ectopic lesions contribute to increased autophagy in VECs by upregulating ERα expression. Enhanced autophagy promotes cytoskeleton formation, migration, and tube formation of VECs by downregulating ECSCR expression, thereby contributing to the characteristic pro-angiogenic microenvironment, aberrant angiogenesis in EMs lesions, and disease progression.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (43)
- Angiogenesis signaling in endometriosis: Molecules, diagnosis and treatment (Review) via openalex
- CircFOXO3 mediates hypoxia-induced autophagy of endometrial stromal cells in endometriosis via openalex
- Dysregulated sphingolipid metabolism and autophagy in granulosa cells of women with endometriosis via openalex
- Endometrial stromal cell ferroptosis promotes angiogenesis in endometriosis via openalex
- Endometriosis-related alterations in the endometrium revealed by integrated single-cell and AI-powered approaches via openalex
- High mobility group box 1 promotes endometriosis under hypoxia by regulating inflammation and autophagy in vitro and in vivo via openalex
- Induction of autophagy by Beclin-1 in granulosa cells contributes to follicular progesterone elevation in ovarian endometriosis via openalex
- Targeting TLR4 Attenuates Endometriosis Progression by Suppressing NF-κB/NLRP3 Inflammasome Activation and Angiogenesis via openalex
- The heterogeneity of fibrosis and angiogenesis in endometriosis revealed by single-cell RNA-sequencing via openalex
- The Role of CEBPD in Oxidative Stress and Angiogenesis Regulation in Endometriosis via openalex
- W2907352183 via openalex
- W2911779714 via openalex
- W2967165574 via openalex
- W3031331119 via openalex
- W3063498583 via openalex
- W3103462108 via openalex
- W3127406385 via openalex
- W3157016020 via openalex
- W3201862089 via openalex
- W3202177173 via openalex
- W3215602721 via openalex
- W4286489005 via openalex
- W4304196289 via openalex
- W4317716423 via openalex
- W4327896728 via openalex
- W4400293079 via openalex
- W4404533020 via openalex
- W4404928933 via openalex
- W4406893596 via openalex
- W1982907736 via openalex
- W4414803708 via openalex
- W4417225897 via openalex
- W7117299049 via openalex
- W4412031312 via openalex
- W1991646791 via openalex
- W2002750600 via openalex
- W2014589536 via openalex
- W2054495963 via openalex
- W2071193569 via openalex
- W2749499656 via openalex
- W2800298102 via openalex
- W2811307141 via openalex
- W2904417497 via openalex
SciLite annotations
chemicals 4
estrogen
estrogen
estrogen
estrogen
organisms 1
transgenic mice
Source provenance
- europepmc
- last seen: 2026-11-10T06:10:21.240273+00:00
- openalex
- last seen: 2026-11-10T06:07:28.844288+00:00
- pubmed
- last seen: 2026-11-10T06:09:14.670230+00:00
- scilite
- last seen: 2026-11-08T10:40:02.467495+00:00
- unpaywall
- last seen: 2026-11-10T06:49:48.839918+00:00
License: public-domain-us
· commercial use OK
· attribution required
Courtesy of the U.S. National Library of Medicine
Courtesy of the U.S. National Library of Medicine